Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.WestPark Capital Analyst
Ed Arce is an analyst at WestPark Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/06/2026 | VERU | Buy Now | Veru | $2.31 | 1112.12% | → $28 | Initiates | → Buy | Get Alert | |
| 09/08/2026 | AKBA | Buy Now | Akebia Therapeutics | $0.68 | 559.73% | → $4.5 | Initiates | → Buy | Get Alert | |
| 04/30/2026 | TLPH | Buy Now | Talphera | $1.07 | 180.37% | → $3 | Initiates | → Buy | Get Alert | |
| 09/30/2025 | ENTA | Buy Now | Enanta Pharma | $11.41 | 145.4% | $24 → $28 | Maintains | Buy | Get Alert | |
| 09/02/2025 | ENTA | Buy Now | Enanta Pharma | $11.41 | 110.34% | → $24 | Initiates | → Buy | Get Alert | |
| 06/11/2025 | TVTX | Buy Now | Travere Therapeutics | $49.83 | -39.8% | → $30 | Assumes | → Buy | Get Alert | |
| 04/16/2025 | MTVA | Buy Now | MetaVia | $1.34 | 795.52% | $12 → $12 | Reiterates | Buy → Buy | Get Alert | |
| 04/11/2025 | UNCY | Buy Now | Unicycive Therapeutics | $3.63 | 106.61% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert | |
| 04/10/2025 | ARCT | Buy Now | Arcturus Therapeutics | $10.42 | 475.82% | $60 → $60 | Reiterates | Buy → Buy | Get Alert | |
| 04/04/2025 | AKBA | Buy Now | Akebia Therapeutics | $0.68 | 999.55% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert | |
| 04/02/2025 | IVA | Buy Now | Inventiva | $3.05 | 326.23% | $13 → $13 | Reiterates | Buy → Buy | Get Alert | |
| 04/02/2025 | GALT | Buy Now | Galectin Therapeutics | $3.50 | — | — | Reiterates | Neutral → Neutral | Get Alert | |
| 04/01/2025 | UNCY | Buy Now | Unicycive Therapeutics | $3.63 | 106.61% | $4 → $7.5 | Maintains | Buy | Get Alert | |
| 04/01/2025 | TLPH | Buy Now | Talphera | $1.07 | 460.75% | $6 → $6 | Reiterates | Buy → Buy | Get Alert | |
| 03/31/2025 | ALGS | Buy Now | Aligos Therapeutics | $5.53 | 1165.82% | $70 → $70 | Reiterates | Buy → Buy | Get Alert | |
| 03/28/2025 | IVA | Buy Now | Inventiva | $3.05 | 326.23% | $13 → $13 | Reiterates | Buy → Buy | Get Alert | |
| 03/27/2025 | DRRX | Buy Now | Durect | — | — | — | Reiterates | Neutral → Neutral | Get Alert | |
| 03/24/2025 | ASMB | Buy Now | Assembly Biosciences | $20.16 | — | — | Reiterates | Neutral → Neutral | Get Alert | |
| 03/21/2025 | MTVA | Buy Now | MetaVia | $1.34 | 795.52% | $12 → $12 | Reiterates | Buy → Buy | Get Alert | |
| 03/19/2025 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.10 | 990.91% | $12 → $12 | Reiterates | Buy → Buy | Get Alert | |
| 03/18/2025 | PLRX | Buy Now | Pliant Therapeutics | $0.90 | — | — | Reiterates | Neutral → Neutral | Get Alert | |
| 03/14/2025 | AKBA | Buy Now | Akebia Therapeutics | $0.68 | 999.55% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert | |
| 03/13/2025 | SGMT | Buy Now | Sagimet Biosciences | $8.74 | 266.13% | → $32 | Reiterates | Buy → Buy | Get Alert | |
| 03/11/2025 | SGMT | Buy Now | Sagimet Biosciences | $8.74 | 266.13% | $32 → $32 | Reiterates | Buy → Buy | Get Alert | |
| 03/11/2025 | ALGS | Buy Now | Aligos Therapeutics | $5.53 | 1165.82% | $75 → $70 | Maintains | Buy | Get Alert | |
| 03/10/2025 | CDTX | Buy Now | Cidara Therapeutics | — | — | $24 → $35 | Maintains | Buy | Get Alert | |
| 03/07/2025 | ARCT | Buy Now | Arcturus Therapeutics | $10.42 | 475.82% | $63 → $60 | Maintains | Buy | Get Alert | |
| 03/04/2025 | PLRX | Buy Now | Pliant Therapeutics | $0.90 | — | — | Reiterates | Neutral → Neutral | Get Alert | |
| 03/03/2025 | AKRO | Buy Now | Akero Therapeutics | — | — | $72 → $75 | Maintains | Buy | Get Alert | |
| 02/28/2025 | ETNB | Buy Now | 89bio | — | — | $29 → $21 | Reiterates | Buy → Buy | Get Alert | |
| 02/28/2025 | MIRM | Buy Now | Mirum Pharmaceuticals | $82.24 | -12.45% | $66 → $72 | Maintains | Buy | Get Alert | |
| 02/27/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $447.09 | -9.41% | $400 → $405 | Maintains | Buy | Get Alert | |
| 02/21/2025 | ARDX | Buy Now | Ardelyx | $3.09 | 77.99% | $5.5 → $5.5 | Reiterates | Neutral → Neutral | Get Alert | |
| 02/18/2025 | RARE | Buy Now | Ultragenyx Pharmaceutical | $15.07 | 530.39% | $95 → $95 | Reiterates | Buy → Buy | Get Alert | |
| 02/18/2025 | ARCT | Buy Now | Arcturus Therapeutics | $10.42 | 504.61% | $63 → $63 | Reiterates | Buy → Buy | Get Alert | |
| 02/14/2025 | RARE | Buy Now | Ultragenyx Pharmaceutical | $15.07 | 530.39% | $95 → $95 | Reiterates | Buy → Buy | Get Alert | |
| 02/14/2025 | ARCT | Buy Now | Arcturus Therapeutics | $10.42 | 504.61% | $63 → $63 | Reiterates | Buy → Buy | Get Alert | |
| 02/14/2025 | PLRX | Buy Now | Pliant Therapeutics | $0.90 | — | — | Reiterates | Neutral → Neutral | Get Alert | |
| 02/11/2025 | ENTA | Buy Now | Enanta Pharma | $11.41 | 57.76% | $18 → $18 | Reiterates | Buy → Buy | Get Alert | |
| 02/10/2025 | PLRX | Buy Now | Pliant Therapeutics | $0.90 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 02/07/2025 | GNFT | Buy Now | Genfit | — | — | $13 → $13 | Reiterates | Buy → Buy | Get Alert | |
| 01/30/2025 | IVA | Buy Now | Inventiva | $3.05 | 326.23% | $13 → $13 | Reiterates | Buy → Buy | Get Alert | |
| 01/29/2025 | UNCY | Buy Now | Unicycive Therapeutics | $3.63 | 10.19% | $4 → $4 | Reiterates | Buy → Buy | Get Alert | |
| 01/27/2025 | AKRO | Buy Now | Akero Therapeutics | — | — | $50 → $72 | Maintains | Buy | Get Alert | |
| 01/23/2025 | AKBA | Buy Now | Akebia Therapeutics | $0.68 | 999.55% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert | |
| 01/21/2025 | ETNB | Buy Now | 89bio | — | — | $29 → $29 | Reiterates | Buy → Buy | Get Alert | |
| 01/21/2025 | ABUS | Buy Now | Arbutus Biopharma | $4.23 | 18.18% | $5 → $5 | Reiterates | Buy → Buy | Get Alert | |
| 01/21/2025 | TLPH | Buy Now | Talphera | $1.07 | 460.75% | $6 → $6 | Reiterates | Buy → Buy | Get Alert | |
| 01/16/2025 | ARDX | Buy Now | Ardelyx | $3.09 | 77.99% | $5.5 → $5.5 | Reiterates | Neutral → Neutral | Get Alert | |
| 01/16/2025 | AKRO | Buy Now | Akero Therapeutics | — | — | $50 → $50 | Reiterates | Buy → Buy | Get Alert | |
| 01/15/2025 | TVTX | Buy Now | Travere Therapeutics | $49.83 | -55.85% | $18 → $22 | Maintains | Buy | Get Alert | |
| 01/14/2025 | AKBA | Buy Now | Akebia Therapeutics | $0.68 | 999.55% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert | |
| 01/14/2025 | NAMS | Buy Now | NewAmsterdam Pharma | $20.81 | 130.66% | $48 → $48 | Reiterates | Buy → Buy | Get Alert | |
| 01/14/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $447.09 | -10.53% | $390 → $400 | Maintains | Buy | Get Alert | |
| 01/13/2025 | ARCT | Buy Now | Arcturus Therapeutics | $10.42 | 504.61% | $63 → $63 | Reiterates | Buy → Buy | Get Alert | |
| 01/13/2025 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.10 | 990.91% | $12 → $12 | Reiterates | Buy → Buy | Get Alert | |
| 01/10/2025 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.10 | 990.91% | $12 → $12 | Reiterates | Buy → Buy | Get Alert | |
| 01/08/2025 | UNCY | Buy Now | Unicycive Therapeutics | $3.63 | 10.19% | $4 → $4 | Maintains | Buy | Get Alert | |
| 01/07/2025 | ARCT | Buy Now | Arcturus Therapeutics | $10.42 | 504.61% | $63 → $63 | Maintains | Buy | Get Alert | |
| 12/30/2024 | MTVA | Buy Now | MetaVia | $1.34 | 795.52% | → $12 | Initiates | → Buy | Get Alert | |
| 12/30/2024 | NAMS | Buy Now | NewAmsterdam Pharma | $20.81 | 130.66% | → $48 | Initiates | → Buy | Get Alert | |
| 12/27/2024 | GALT | Buy Now | Galectin Therapeutics | $3.50 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 12/27/2024 | ASMB | Buy Now | Assembly Biosciences | $20.16 | — | — | Reiterates | Neutral → Neutral | Get Alert | |
| 12/24/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $15.07 | 530.39% | $95 → $95 | Reiterates | Buy → Buy | Get Alert | |
| 12/24/2024 | ENTA | Buy Now | Enanta Pharma | $11.41 | 57.76% | $27 → $18 | Maintains | Buy | Get Alert | |
| 12/17/2024 | ARCT | Buy Now | Arcturus Therapeutics | $10.42 | 504.61% | $63 → $63 | Reiterates | Buy → Buy | Get Alert | |
| 12/10/2024 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.10 | 990.91% | $12 → $12 | Reiterates | Buy → Buy | Get Alert | |
| 12/04/2024 | TERN | Buy Now | Terns Pharma | — | — | $7.5 → $7.5 | Reiterates | Neutral → Neutral | Get Alert | |
| 11/18/2024 | AKRO | Buy Now | Akero Therapeutics | — | — | $50 → $50 | Reiterates | Buy → Buy | Get Alert | |
| 11/18/2024 | ABUS | Buy Now | Arbutus Biopharma | $4.23 | 18.18% | $5 → $5 | Reiterates | Buy → Buy | Get Alert | |
| 11/15/2024 | SGMT | Buy Now | Sagimet Biosciences | $8.74 | 266.13% | $32 → $32 | Reiterates | Buy → Buy | Get Alert | |
| 11/15/2024 | GALT | Buy Now | Galectin Therapeutics | $3.50 | 214.74% | $11 → $11 | Reiterates | Buy → Buy | Get Alert | |
| 11/14/2024 | UNCY | Buy Now | Unicycive Therapeutics | $3.63 | 10.19% | $2.5 → $4 | Maintains | Buy | Get Alert | |
| 11/14/2024 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.10 | 990.91% | $12 → $12 | Reiterates | Buy → Buy | Get Alert | |
| 11/14/2024 | DRRX | Buy Now | Durect | — | — | — | Reiterates | → Neutral | Get Alert | |
| 11/13/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $82.24 | -19.75% | $66 → $66 | Reiterates | Buy → Buy | Get Alert | |
| 11/13/2024 | TERN | Buy Now | Terns Pharma | — | — | $5.5 → $7.5 | Maintains | Neutral | Get Alert | |
| 11/12/2024 | UNCY | Buy Now | Unicycive Therapeutics | $3.63 | -31.13% | $2.5 → $2.5 | Reiterates | Buy → Buy | Get Alert | |
| 11/11/2024 | ARDX | Buy Now | Ardelyx | $3.09 | 77.99% | $11 → $5.5 | Downgrade | Buy → Neutral | Get Alert | |
| 11/11/2024 | AKRO | Buy Now | Akero Therapeutics | — | — | $50 → $50 | Reiterates | Buy → Buy | Get Alert | |
| 11/11/2024 | CDTX | Buy Now | Cidara Therapeutics | — | — | $24 → $24 | Reiterates | Buy → Buy | Get Alert | |
| 11/11/2024 | ETNB | Buy Now | 89bio | — | — | $29 → $29 | Reiterates | Buy → Buy | Get Alert | |
| 11/08/2024 | PLRX | Buy Now | Pliant Therapeutics | $0.90 | 4122.22% | $38 → $38 | Reiterates | Buy → Buy | Get Alert | |
| 11/08/2024 | ARCT | Buy Now | Arcturus Therapeutics | $10.42 | 504.61% | $63 → $63 | Reiterates | Buy → Buy | Get Alert | |
| 11/07/2024 | ABUS | Buy Now | Arbutus Biopharma | $4.23 | 18.18% | $5 → $5 | Reiterates | Buy → Buy | Get Alert | |
| 11/07/2024 | ALGS | Buy Now | Aligos Therapeutics | $5.53 | 1256.24% | $75 → $75 | Reiterates | Buy → Buy | Get Alert | |
| 11/06/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $15.07 | 530.39% | $82 → $95 | Maintains | Buy | Get Alert | |
| 11/01/2024 | ARDX | Buy Now | Ardelyx | $3.09 | 255.99% | $11 → $11 | Reiterates | Buy → Buy | Get Alert | |
| 10/31/2024 | SGMT | Buy Now | Sagimet Biosciences | $8.74 | 266.13% | $32 → $32 | Reiterates | Buy → Buy | Get Alert | |
| 10/23/2024 | AKBA | Buy Now | Akebia Therapeutics | $0.68 | 999.55% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert | |
| 10/23/2024 | ALGS | Buy Now | Aligos Therapeutics | $5.53 | 1256.24% | $75 → $75 | Reiterates | Buy → Buy | Get Alert | |
| 10/22/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $447.09 | -12.77% | $390 → $390 | Reiterates | Buy → Buy | Get Alert | |
| 10/22/2024 | CDTX | Buy Now | Cidara Therapeutics | — | — | $24 → $24 | Reiterates | Buy → Buy | Get Alert | |
| 10/15/2024 | IVA | Buy Now | Inventiva | $3.05 | 326.23% | $14 → $13 | Maintains | Buy | Get Alert | |
| 10/11/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $82.24 | -19.75% | $66 → $66 | Reiterates | Buy → Buy | Get Alert | |
| 10/11/2024 | GNFT | Buy Now | Genfit | — | — | $13 → $13 | Reiterates | Buy → Buy | Get Alert | |
| 10/10/2024 | AKBA | Buy Now | Akebia Therapeutics | $0.68 | 999.55% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert | |
| 10/10/2024 | ENTA | Buy Now | Enanta Pharma | $11.41 | 136.63% | $27 → $27 | Reiterates | Buy → Buy | Get Alert | |
| 10/09/2024 | UNCY | Buy Now | Unicycive Therapeutics | $3.63 | -31.13% | $2.5 → $2.5 | Reiterates | Buy → Buy | Get Alert | |
| 10/08/2024 | AKBA | Buy Now | Akebia Therapeutics | $0.68 | 999.55% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert |

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.





